Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women

References

• Chompootweep S, Tankeyoon M, Yamarat K, et al. The menopausal age and climacteric complaints in Thai women in Bangkok. Maturitas 1993;17:63–71
   PubMed Web of Science ®Google Scholar
• Chua Y, Limpaphayom KK, Cheng B, et al. Genitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey. Climacteric 2017;20:367–73
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Lehert P, Burger H, et al. Factors affecting sexual functioning of women in the mid-life years. Climacteric 1999;2:254–62
   PubMedGoogle Scholar
• Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric 2008;11:181–91
   PubMed Web of Science ®Google Scholar
• Schwenkhagen A, Studd J. Role of testosterone in the treatment of hypoactive sexual desire disorder. Maturitas 2009;63:152–9
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682–8
   PubMed Web of Science ®Google Scholar
• Krapf JM, Simon JA. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 2009;63:213–19
   PubMed Web of Science ®Google Scholar
• Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006;13:770–9
   PubMed Web of Science ®Google Scholar
• Kingsberg S, Shifren J, Wekselman K, et al. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007;4:1001–8
   PubMed Web of Science ®Google Scholar
• Somboonporn W, Davis S, Seif MW, et al. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005;4:CD004509
   Google Scholar
• Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril 2007;88:1–17
   PubMed Web of Science ®Google Scholar
• Shifren JL, Davis SR. Androgens in postmenopausal women: a review. Menopause 2017;24:970–9
   PubMed Web of Science ®Google Scholar
• Miller KK, Biller BM, Beauregard C, et al. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683–90
   PubMed Web of Science ®Google Scholar
• Wang C, Berman N, Longstreth JA, et al. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. J Clin Endocrinol Metab 2000;85:964–9
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensioanal self-report instrument for the assessment of sexual function. J Sex Marital Ther 2000;26:191–208
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1–20
   PubMed Web of Science ®Google Scholar
• Morris PD, Malkin CJ, Channer KS, et al. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 2004;151:241–9
   PubMed Web of Science ®Google Scholar
• Sodergard R, Backstrom T, Shanbhag V, et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801–10
   PubMedGoogle Scholar
• Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944–52
   PubMed Web of Science ®Google Scholar
• Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226–33
   PubMed Web of Science ®Google Scholar
• Nijland EA, Weijmar Schultz WC, Nathorst-Boös J, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med 2008;5:646–56
   PubMed Web of Science ®Google Scholar
• Constantine G, Graham S, Portman DJ, et al. Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, plecebo-controlled trial. Climacteric 2015;18:226–32
   PubMed Web of Science ®Google Scholar
• Fernandes T, Costa‐Paiva LH, Pinto‐Neto AM. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial. J Sex Med 2014;11:1262–70
   PubMed Web of Science ®Google Scholar
• Pesant MH, Desmarais G, Fink GD, et al. Reference ranges for total and calculated free and bioavailable testosterone in a young healthy women population with normal menstrual cycles or using oral contraception. Clin Biochem 2012;45:148–50
   PubMed Web of Science ®Google Scholar
• Davis SR, Davison SL, Donath S, et al. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6
   PubMed Web of Science ®Google Scholar
• Tungmunsakulchai R, Chaikittisilpa S, Snabboon T, et al. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women. BMC Womens Health 2015;15:113
   PubMed Web of Science ®Google Scholar
• Stephenson KR, Toorabally N, Lyons L, et al. Further validation of the female sexual function index: specificity and associations with clinical interview data. J Sex Marital Ther 2016;42:448–61
   PubMed Web of Science ®Google Scholar